Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07215624 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

Study acronym: STOP-VTE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 59 → 103 locations
  2. Secondary endpoints: details revised at 1 of 3 entries
    • Site details revised at 4 of 59 sites
    • Eligibility criteria expanded, about 1 word
  3. Trial sites expanded: 41 → 59 locationsv10
  4. Study sites: 28 to 41v9
  5. Study sites: 3 to 28v8
Show 6 earlier versionsHide 6 earlier versions
  1. Start date: Dec 2, 2025 to Jan 15, 2026v7
  2. Study sites: 1 to 3v6
  3. Re-verified, no change to tracked fieldsv5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date: Dec 10, 2025 to Dec 2, 2025
    v4
  5. Start date: Nov 10, 2025 to Dec 10, 2025v3
  6. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study evaluates the use of extended venous thromboembolism prophylaxis (ePPx) following abdominopelvic cancer surgery within the NCI Community Oncology Research Program (NCORP) network, targeting surgeons and surgical advanced practice providers (APPs).
Trial Details
NCT Number NCT07215624
Lead Sponsor Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm, Malignant Genitourinary System Neoplasm
Related terms Gastrointestinal Neoplasms, Urogenital Neoplasms
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov